Yaz Approval History
- FDA approved: Yes (First approved March 16th, 2006)
- Brand name: Yaz
- Generic name: drospirenone and ethinyl estradiol
- Dosage form: Tablets
- Company: Berlex, Inc.
- Treatment for: Acne, Birth Control, Premenstrual Dysphoric Disorder
Yaz (drospirenone and ethinyl estradiol) is a combination oral contraceptive indicated for prevention of pregnancy in women who elect to use an oral contraceptive, treatment of symptoms of premenstrual dysphoric disorder and for the treatment of moderate acne vulgaris.
Development History and FDA Approval Process for Yaz
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.